Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: takeover

Shareholders approve hedge fund Alden’s takeover of Tribune, owner of Baltimore Sun (access required)

Shareholders of Tribune Publishing, one of the country’s largest newspaper chains and the owner of The Baltimore Sun, approved a $630 million takeover bid by hedge fund Alden Global Capital on Friday, the company said in a brief statement.

Read More »

Judge refuses to delay Glaxo-Human Genome deal

DOVER, Del. — A federal judge in Delaware has refused to issue a restraining order delaying the acquisition of Human Genome Sciences Inc. by GlaxoSmithKline. Two HGS shareholders had argued that the tender offer period should be extended beyond Friday’s ...

Read More »

GlaxoSmithKline wins takeover bid for Human Genome

U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK’s drug portfolio in crucial areas: biologic drugs and treatments for the hundreds of millions of people ...

Read More »

Report: GSK in deal talks with Human Genome

NEW YORK — GlaxoSmithKline PLC is reportedly talking this weekend with Human Genome Sciences Inc. about its $2.6 billion offer for the Rockville-based biotech company. British drug maker GlaxoSmithKline made its first bid for the biotech company in April and ...

Read More »

GlaxoSmithKline in takeover bid for Human Genome

LONDON — GlaxoSmithKline PLC has made an offer to take over Rockville-based drug maker Human Genome Sciences Inc. which values the company at nearly $2.6 billion. GlaxoSmithKline, which has profit-sharing agreements with HGS on three drugs but a minimal shareholding, ...

Read More »